Seoul, South Korea

Yongjoon Han

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Eoflow Inc., Ipv Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongjoon Han. Retrieved from https://idiyas.com/inventor/yongjoon-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Yongjoon Han

Introduction

Yongjoon Han is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology through his innovative designs and patents. His work focuses on improving the delivery of medical liquids, which is crucial for patient care.

Latest Patents

Yongjoon Han holds a patent for an "Apparatus for infusing medical liquid." This apparatus includes a needle module designed to be injected into a user's body, a medical liquid storage portion that holds the liquid, and a driving portion that transfers the liquid to the needle module. This invention aims to enhance the efficiency and safety of medical liquid infusion.

Career Highlights

Yongjoon Han is currently associated with Ipv Limited, where he continues to develop innovative solutions in the medical field. His expertise and dedication to improving medical technologies have positioned him as a valuable asset in his company.

Conclusion

Yongjoon Han's contributions to medical technology through his patent demonstrate his commitment to innovation and improving patient care. His work is a testament to the importance of inventors in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…